GlassScriptPhysician profile
Leon A Yasay
NPI 1295719250
$4,955.53
in general payments reported to CMS, 2019-2025
39 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $190 · 2021: $224 · 2022: $673 · 2023: $1,051 · 2024: $1,430 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,604.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $767.27 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $686.91 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $320.61 | 2019-2025 | Vraylar, Qulipta, Synthroid |
| Amgen INC. | $314.91 | 2022-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $269.86 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $255.15 | 2022-2024 | Quviviq |
| Exact Sciences Corporation | $220.83 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $215.87 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $210.74 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $203.28 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $133.75 | 2022-2024 | |
| Heartflow, INC. | $129.98 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $128.43 | 2023-2024 | Austedo Xr |
| Inspire Medical Systems, INC. | $106.46 | 2024 | Inspire |
| Dexcom, INC. | $104.63 | 2022-2024 | Dexcom G6 Transmitter |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Yasay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.